Rosuvastatin upregulates the antioxidant defense protein heme oxygenase-1

Biochemical and Biophysical Research Communications

Volumn 325, Issue 3, 2004, Pages 871-876

  Grosser, N ^a   Erdmann, K ^a   Hemmerle, A ^a   Berndt, G ^a   Hinkelmann, U ^a   Smith, G ^b   Schroder H ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b ASTRAZENECA   (United Kingdom)

Author keywords

Antioxidant; Bilirubin; Cytoprotection; Endothelial cells; Free radicals; Gene expression; Heme oxygenase; HMG CoA reductase inhibitor; Pleiotropic action; Rosuvastatin

Indexed keywords

ANTIOXIDANT; BILIRUBIN; HEME OXYGENASE 1; ISOPRENOID; MESSENGER RNA; MEVALONIC ACID; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; OXYGEN RADICAL; PROTOPORPHYRIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; ROSUVASTATIN;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN TARGETING; RNA ANALYSIS; UPREGULATION;

ANTIOXIDANTS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; FLUOROBENZENES; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; HUMANS; MEMBRANE PROTEINS; PYRIMIDINES; REACTIVE OXYGEN SPECIES; SULFONAMIDES; UP-REGULATION;

EID: 8444233164     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.10.123     Document Type: Article

References (41)

1. D.J. Maron, S. Fazio, and M.F. Linton Current perspectives on statins Circulation 101 2000 207 213
2. S.K. Ganesh, C.M. Nass, and R.S. Blumenthal Anti-atherosclerotic effects of statins: lessons from prevention trials J. Cardiovasc. Risk. 10 2003 155 159
3. J.C. LaRosa Statins and risk of coronary heart disease JAMA 283 2000 2935 2936
4. C.J. Vaughan, A.M. Gotto Jr., and C.T. Basson The evolving role of statins in the management of atherosclerosis J. Am. Coll. Cardiol. 35 2000 1 10
5. M.J. Klag, D.E. Ford, L.A. Mead, J. He, P.K. Whelton, K.Y. Liang, and D.M. Levine Serum cholesterol in young men and subsequent cardiovascular disease N. Engl. J. Med. 328 1993 313 318
6. Z.A. Massy, W.F. Keane, and B.L. Kasiske Inhibition of the mevalonate pathway: benefits beyond cholesterol reduction? Lancet 347 1996 102 103
7. A.S. Wierzbicki, R. Poston, and A. Ferro The lipid and non-lipid effects of statins Pharmacol. Ther. 99 2003 95 112
8. U. Laufs, K. Gertz, U. Dirnagl, M. Bohm, G. Nickenig, and M. Endres Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice Brain Res. 942 2002 23 30
9. Y.H. Chen, S.J. Lin, M.W. Lin, H.L. Tsai, S.S. Kuo, J.W. Chen, M.J. Charng, T.C. Wu, L.C. Chen, Y.A. Ding, W.H. Pan, Y.S. Jou, and L.Y. Chau Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients Hum. Genet. 111 2002 1 8
10. L.E. Otterbein, B.S. Zuckerbraun, M. Haga, F. Liu, R. Song, A. Usheva, C. Stachulak, N. Bodyak, R.N. Smith, E. Csizmadia, S. Tyagi, Y. Akamatsu, R.J. Flavell, T.R. Billiar, E. Tzeng, F.H. Bach, A.M. Choi, and M.P. Soares Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury Nat. Med. 9 2003 183 190
11. S.F. Yet, M.D. Layne, X. Liu, Y.H. Chen, B. Ith, N.E. Sibinga, and M.A. Perrella Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling FASEB J. 17 2003 1759 1761
12. D.E. Baranano, M. Rao, C.D. Ferris, and S.H. Snyder Biliverdin reductase: a major physiologic cytoprotectant Proc. Natl. Acad. Sci. USA 99 2002 16093 16098
13. N. Grosser, A. Abate, S. Oberle, H.J. Vreman, P.A. Dennery, J.C. Becker, T. Pohle, D.S. Seidman, and H. Schroder Heme oxygenase-1 induction may explain the antioxidant profile of aspirin Biochem. Biophys. Res. Commun. 308 2003 956 960
14. S. Immenschuh, and G. Ramadori Gene regulation of heme oxygenase-1 as a therapeutic target Biochem. Pharmacol. 60 2000 1121 1128
15. L.E. Otterbein, and A.M. Choi Heme oxygenase: colors of defense against cellular stress Am. J. Physiol. Lung Cell. Mol. Physiol. 279 2000 L1029 1037
16. T. Polte, A. Abate, P.A. Dennery, and H. Schroder Heme oxygenase-1 is a cGMP-inducible endothelial protein and mediates the cytoprotective action of nitric oxide Arterioscler. Thromb. Vasc. Biol. 20 2000 1209 1215
17. T. Polte, A. Hemmerle, G. Berndt, N. Grosser, A. Abate, and H. Schroder Atrial natriuretic peptide reduces cyclosporin toxicity in renal cells: role of cGMP and heme oxygenase-1 Free Radic. Biol. Med. 32 2002 56 63
18. S.W. Ryter, L.E. Otterbein, D. Morse, and A.M. Choi Heme oxygenase/carbon monoxide signaling pathways: regulation and functional significance Mol. Cell. Biochem. 234-235 2002 249 263
19. S. Immenschuh, V. Hinke, A. Ohlmann, S. Gifhorn-Katz, N. Katz, K. Jungermann, and T. Kietzmann Transcriptional activation of the haem oxygenase-1 gene by cGMP via a cAMP response element/activator protein-1 element in primary cultures of rat hepatocytes Biochem. J. 334 1 1998 141 146
20. A.K. Kiemer, N. Bildner, N.C. Weber, and A.M. Vollmar Characterization of heme oxygenase 1 (heat shock protein 32) induction by atrial natriuretic peptide in human endothelial cells Endocrinology 144 2003 802 812
21. P.N. Hopkins, L.L. Wu, S.C. Hunt, B.C. James, G.M. Vincent, and R.R. Williams Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease Arterioscler. Thromb. Vasc. Biol. 16 1996 250 255
22. M. Mayer Association of serum bilirubin concentration with risk of coronary artery disease Clin. Chem. 46 2000 1723 1727
23. S.M. Keyse, and R.M. Tyrrell Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite Proc. Natl. Acad. Sci. USA 86 1989 99 103
24. K. Suda, B. Rothen-Rutishauser, M. Gunthert, and H. Wunderli-Allenspach Phenotypic characterization of human umbilical vein endothelial (ECV304) and urinary carcinoma (T24) cells: endothelial versus epithelial features In Vitro Cell Dev. Biol. Anim. 37 2001 505 514
25. N. Grosser, and H. Schroder Aspirin protects endothelial cells from oxidant damage via the nitric oxide-cGMP pathway Arterioscler. Thromb. Vasc. Biol. 23 2003 1345 1351
26. S. Oberle, T. Polte, A. Abate, H.P. Podhaisky, and H. Schroder Aspirin increases ferritin synthesis in endothelial cells: a novel antioxidant pathway Circ. Res. 82 1998 1016 1020
27. Y. Li, H. Zhu, P. Kuppusamy, V. Roubaud, J.L. Zweier, and M.A. Trush Validation of lucigenin (bis-N-methylacridinium) as a chemilumigenic probe for detecting superoxide anion radical production by enzymatic and cellular systems J. Biol. Chem. 273 1998 2015 2023
28. A. Siegert, C. Denkert, A. Leclere, and S. Hauptmann Suppression of the reactive oxygen intermediates production of human macrophages by colorectal adenocarcinoma cell lines Immunology 98 1999 551 556
29. J.D. Finder, J.L. Litz, M.A. Blaskovich, T.F. McGuire, Y. Qian, A.D. Hamilton, P. Davies, and S.M. Sebti Inhibition of protein geranylgeranylation causes a superinduction of nitric-oxide synthase-2 by interleukin-1beta in vascular smooth muscle cells J. Biol. Chem. 272 1997 13484 13488
30. U. Laufs, and J.K. Liao Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase J. Biol. Chem. 273 1998 24266 24271
31. T.M. Seasholtz, M. Majumdar, D.D. Kaplan, and J.H. Brown Rho and Rho kinase mediate thrombin-stimulated vascular smooth muscle cell DNA synthesis and migration Circ. Res. 84 1999 1186 1193
32. K.K. Koh, J.W. Son, J.Y. Ahn, D.K. Jin, H.S. Kim, Y.M. Choi, D.S. Kim, E.M. Jeong, G.S. Park, I.S. Choi, and E.K. Shin Comparative effects of diet and statin on NO bioactivity and matrix metalloproteinases in hypercholesterolemic patients with coronary artery disease Arterioscler. Thromb. Vasc. Biol. 22 2002 e19 e23
33. U. Laufs, K. Gertz, P. Huang, G. Nickenig, M. Bohm, U. Dirnagl, and M. Endres Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice Stroke 31 2000 2442 2449
34. R. Shibata, H. Kai, Y. Seki, S. Kato, M. Morimatsu, K. Kaibuchi, and T. Imaizumi Role of rho-associated kinase in neointima formation after vascular injury Circulation 103 2001 284 289
35. M. Eto, T. Kozai, F. Cosentino, H. Joch, and T.F. Luscher Statin prevents tissue factor expression in human endothelial cells: role of Rho/Rho-kinase and Akt pathways Circulation 105 2002 1756 1759
36. X.F. Ming, H. Viswambharan, C. Barandier, J. Ruffieux, K. Kaibuchi, S. Rusconi, and Z. Yang Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells Mol. Cell. Biol. 22 2002 8467 8477
37. W. Durante, M.H. Kroll, N. Christodoulides, K.J. Peyton, and A.I. Schafer Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells Circ. Res. 80 1997 557 564
38. E.L. Yee, B.R. Pitt, T.R. Billiar, and Y.M. Kim Effect of nitric oxide on heme metabolism in pulmonary artery endothelial cells Am. J. Physiol. 271 1996 L512 518
39. R. Stocker, Y. Yamamoto, A.F. McDonagh, A.N. Glazer, and B.N. Ames Bilirubin is an antioxidant of possible physiological importance Science 235 1987 1043 1046
40. T.S. Lee, C.C. Chang, Y. Zhu, and J.Y. Shyy Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection Circulation 110 2004 1296 1302
41. F. Mach Statins as novel immunomodulators: from cell to potential clinical benefit Thromb. Haemost. 90 2003 607 610